able lateralizing information to facilitate decision making are therefore needed. Fluorine-18 fluorodeoxyglucose positron emission tomography ( 18 F-FDG PET) is an established diagnostic tool that helps to delineate the epileptogenic zone and to gain information about the functional state of the "remaining" parts of the brain, especially in the absence of radiographic lesions. 12, 17, 21 In patients with temporal lobe epilepsy, the presence of extratemporal hypometabolism, ipsilateral and/or contralateral to the epileptogenic focus, was associated with higher rates of unfavorable seizure outcomes after surgery. 1, 2, 23, 26 However, data are limited concerning the prognostic value of PET in children evaluated for hemispherotomy. 6, 18, 19 Moosa et al. reported that presurgical
18
F-FDG PET identifying or excluding hypometabolic areas in the contralateral remaining hemisphere can provide prognostic information. 15 The purpose of this study was to investigate the lateralizing value of 18 F-FDG PET compared with MRI in children and adolescents with drug-resistant hemispheric epilepsies. The hypothesis was that PET is a reliable tool to obtain additional information supporting the surgical approach, even in cases with inconclusive or bilateral MRI findings. Therefore,
F-FDG PET and MRI data obtained during the presurgical diagnostic process were reevaluated in relation to seizure outcomes after hemispherotomy.
Methods study Population
All clinical data used in this study were obtained from a longitudinal observational database of the pediatric epilepsy center at the Medical University of Vienna maintained by a senior neurologist familiar with the patients (M.F.). The database contains the complete medical records of all children and adolescents ≤ 18 years of age who have undergone presurgical evaluation and epilepsy surgery since 1999, including retrospective data on patient demographics, medical history, seizure types, and epilepsy syndromes, as well as prospectively collected data on presurgical evaluation, surgery, histopathology, developmental and seizure outcome, and antiepileptic drug use/ withdrawal after surgery. 5, 8 Follow-up data are collected on an inpatient basis 3 and 12 months after surgery and annually thereafter.
Study inclusion criteria were 1) drug-resistant hemispheric epilepsy; 2) hemispherotomy performed at the study center; 3) availability of 18F-FDG PET studies performed prior to surgery; 4) availability of MRI studies with epilepsy-specific imaging protocols performed prior to surgery; and 5) complete follow-up data of at least 12 months after surgery. This study was approved by the ethics committee of the Medical University of Vienna.
Presurgical neuroimaging and interpretation

18
F-FDG PET examinations were performed as part of a standardized presurgical evaluation program at the Division of Nuclear Medicine of the Department of Biomedical Imaging and Image-guided Therapy at the Medical University of Vienna. PET acquisition and reconstruction were performed by a dedicated full-ring GE Advance PET scanner (GE Medical Systems). Spatial resolution of the scanner amounts to 4.0 mm in the axial direction and 3.8 mm in the tangential direction.
F-FDG was freshly prepared every day according to a well-established method using the GE FASTlab platform (GE Healthcare). 10 After injection of 18 F-FDG according to the European Association of Nuclear Medicine recommendations for children, a 3-minute transmission scan for attenuation correction was acquired at the beginning of the scanning procedure. MRI studies were performed at the Division of Neuro-and Muskuloskeletal Radiology of the Department of Biomedical Imaging and Image-guided Therapy during presurgical evaluation, using either a 1.5-T (Philips Intera) or a 3.0-T machine (Siemens Trio). The protocols applied included at least anatomical, thin-slice volumetric T1-weighted gradient-recalled echo sequences (1 mm isotropic resolution), coronal T2-weighted sequences (2-4 mm slice thickness), axial FLAIR and inversion recovery sequences (2-mm slice thickness), and high-resolution paracoronal FLAIR and T2-weighted sequences acquired perpendicular to the main axis of the hippocampus (2-mm slice thickness). Data were sent to a picture archiving and communication system (Agfa System) and reinterpreted visually by a board-certified neuroradiologist trained in epilepsy and blinded to the patient's clinical data and PET (G. Kasprian).
seizure outcome evaluation after hemispherotomy
Seizure outcome after hemispherotomy was classified according to the International League Against Epilepsy (ILAE) proposal based on patient and family reporting.
22
This classification takes into account fluctuations in seizure frequency after surgery. For this study seizure outcome was simplified to seizure freedom versus ongoing seizures.
statistical analysis
Because of the small sample size only descriptive analysis was used. Pathological findings and their association with postsurgical outcomes were displayed in absolute and relative frequencies.
results
Clinical Data and seizure Frequencies after hemispherotomy
Fifty-five patients were screened, and 20 were excluded from further analysis because of incomplete MRI and/ or PET data. Data from 35 patients (17 girls) with a median age of 5 years at the time of surgery were analyzed. The surgical technique applied in all patients was vertical perithalamic hemispherotomy. All operations were performed by the same neurosurgeon (T. C.) between December 1999 and June 2013.
The underlying pathologies were vascular defects in 18 patients, malformations of cortical development (MCD) in 9, encephalitis including Rassmussen encephalitis in 3, Sturge-Weber syndrome in 3, and tumors in 2 patients (Table 1 ). The mean follow-up-period was 39.43 months (range 12-144 months). Seizure freedom (Wieser Class 1a) after surgery was observed in 32 patients (91.4%). Three patients (8.6%) were not seizure free: Cases 10, F-FDG distribution patterns in both hemispheres were not found in any of the patients, the study population was divided into two groups with respect to unilateral (Group A, 23/35 patients) or bilateral hypometabolic brain regions (Group B, 12/35 patients). Seizure-freedom after surgery was observed in 100% (23/23) of the patients in Group A and in 75% (9/12) of the children in Group B (Table 2) .
MRI showed unilateral findings in 79.9% (28/35) of the children, and 96.4% (27/28) of them were seizure free after hemispherotomy. MRI was bilateral in 20% (7/35) of the patients, and only 71.4% (5/7) of them were seizure free after surgery.
According to the results of both imaging modalities, patients were assigned to 4 groups (Groups AI and AII, and Groups BI and BII). As noted in Table 2 , seizure freedom after surgery was achieved in 100% of the patients in Group AII (unilateral PET hypometabolism, bilateral MRI findings) compared with only 87.5% of the patients in Group BI (bilateral PET hypometabolism, unilateral MRI findings).
Discussion
At least 35% of all infants and children with epilepsy are pharmacoresistant.
14,24 Many of them suffer from early-onset epileptic encephalopathies due to multilobar/ hemispheric pathologies. Hemispheric resection/disconnection has become an increasingly performed and successful treatment option in carefully selected children, and median seizure-free rates of 73.4% (range 40%-94%) have been reported. 7 In particular, the vertical approach of hemispherotomy was confirmed by our group to be safe and effective, with seizure-free rates of 92%.
4,5
Prerequisites of favorable outcomes after surgery are the precise lateralization of the hemisphere harboring the epileptogenic zone as well as the proven integrity of the remaining contralateral hemisphere. Unfortunately, many of these infants and young children do not show lateralizing seizure semiology and/or interictal/ictal EEG findings. Neuroimaging studies are therefore of paramount importance during the presurgical evaluation process. Structural MRI gives information about the localization and extent of the epileptogenic lesion and may also reveal structural abnormalities in unaffected brain areas. 27 However, the significance of contralateral abnormalities in patients evaluated for hemispheric surgery is controversial. Hallbook et al. reported that contralateral MRI findings, less prominent than those in the ipsilateral hemisphere, do not correlate with seizure outcome and therefore may not be a contraindication in otherwise favorable candidates. 9 In contrast, Moosa et al. observed a poorer outcome in children with bilateral MRI abnormalities after hemispherectomy. 16 PET-based and SPECT-based techniques have also been investigated with respect to their value for both a better delineation of the functional deficit zone prior to surgery and the prediction of possible functional deficits after surgery. 13 The largest outcome study after hemispheric surgery (based on 170 patients) was published in 2013. 15 In this retrospective study,
18
F-FDG PET as well as MRI findings were found to be of prognostic value for postsurgical seizure outcomes. In addition, multivariate analyses identified bilateral 18 F-FDG PET findings as one of the two most valid negative outcome predictors, whereas MRI findings did not correlate with seizure outcome. In our study, we found postoperative seizure freedom in 100% of the children with unilateral pathological glucose metabolism compared with only 75% of those with bilateral pathological FDG PET. Our results corroborate those of the Cleveland group (72% vs 44% seizure-free rates). Furthermore, seizure freedom after hemispherotomy was observed in 96.4% of the patients with unilateral versus only 71.4% of those with bilateral MRI findings. Finally, patients with concordant unilateral findings in both neuroimaging modalities showed seizure free rates of 100% (Fig. 1) . This result underlines the value of a multimodal neuroimaging evaluation prior to hemispherotomy as already recommended by others.
12,13
Most interestingly, seizure freedom was also achieved in 100% of the patients with unilateral PET despite bilateral MRI (Group AII; Fig. 2 ) but only in 87.5% of the patients with bilateral PET and unilateral MRI (Group BI; Table 2 ). Our results may reflect the pathophysiological mechanisms of functional deficits, which are suspected to be responsible for hypometabolism in 18 F-FDG PET. 12, 20 Patients with bilaterally reduced glucose metabolism are suspected to have a "bilateral" disease, even when no structural correlate can be detected by MRI, and thus may have a higher risk of ongoing seizures after surgery.
In summary, PET appears to yield important additional information in patients with unilateral MRI but-almost more importantly-appears to be of crucial importance in cases with bilateral MRI findings. In this context, the radiation exposure by PET imaging as well as the semi-invasive procedure of general anesthesia, which is needed in most of the infants and children with early onset epilepsy syndromes, seems to be justified. 3 This also explains why our PET data were analyzed only visually due to the lack of standardized normal 18 F-FDG brain controls for semiquantitative assessment in infants and children.
The small sample size of this study and the nonhomogeneity with respect to etiology allowed only descriptive data analysis. The retrospective, cross-sectional nature of this study implies a bias in the selection of our cohort. In addition, outcomes of different pathologies are known to be different (MCD vs ischemic lesions) and thus also may have biased the results. Furthermore, the main parameters we wanted to correlate with surgical outcome-presurgical 18 F-FDG PET and MRI findings-were already a factor in the presurgical evaluation process, which shaped our cohort.
However, all PET and MRI examinations were performed in a standardized fashion and reevaluated by specialists blinded to the patients' clinical data. Disconnection of the hemispheres is a highly effective but also complex procedure in the treatment of pharmacoresistant epilepsy. Trained and experienced surgeons are needed for excellent outcome. Our small group of patients was operated on by the same neurosurgeon using the vertical perithalamic surgical approach. Nevertheless, to our best knowledge, there is no other study that reported a similar prediction of seizure recurrence by bilateral 
Conclusions
Infants and children with pharmacoresistant epilepsies should undergo a comprehensive examination including EEG, seizure semiology, and presurgical imaging with MRI and 
